Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer

PURPOSE: Despite decreased screening-based detection of clinically insignificant tumors, most diagnosed prostate cancers are still indolent, indicating a need for better strategies for detection of clinically significant disease before treatment. We hypothesized that patients with detectable circula...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JCO Precis Oncol
Main Authors: Hennigan, S. Thomas, Trostel, Shana Y., Terrigino, Nicholas T., Voznesensky, Olga S., Schaefer, Rachel J., Whitlock, Nichelle C., Wilkinson, Scott, Carrabba, Nicole V., Atway, Rayann, Shema, Steven, Lake, Ross, Sweet, Amalia R., Einstein, David J., Karzai, Fatima, Gulley, James L., Chang, Peter, Bubley, Glenn J., Balk, Steven P., Ye, Huihui, Sowalsky, Adam G.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2019
Assuntos:
Original Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6746181/
https://ncbi.nlm.nih.gov/pubmed/31528835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00176
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares